GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 118 filers reported holding GENOMIC HEALTH INC in Q4 2013. The put-call ratio across all filers is 3.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $186,800,000 | +13.5% | 2,754,343 | -2.6% | 0.01% | +16.7% |
| Q2 2019 | $164,520,000 | -6.9% | 2,828,265 | +12.1% | 0.01% | -14.3% |
| Q1 2019 | $176,752,000 | +17.5% | 2,523,218 | +8.0% | 0.01% | 0.0% |
| Q4 2018 | $150,491,000 | -0.4% | 2,336,453 | +8.6% | 0.01% | +16.7% |
| Q3 2018 | $151,109,000 | +65.3% | 2,151,932 | +18.6% | 0.01% | +50.0% |
| Q2 2018 | $91,440,000 | +74.1% | 1,814,268 | +8.1% | 0.00% | +100.0% |
| Q1 2018 | $52,533,000 | -8.5% | 1,678,954 | +0.0% | 0.00% | -33.3% |
| Q4 2017 | $57,419,000 | +6.6% | 1,678,920 | -0.0% | 0.00% | 0.0% |
| Q3 2017 | $53,883,000 | -0.9% | 1,679,122 | +0.5% | 0.00% | 0.0% |
| Q2 2017 | $54,379,000 | +10.4% | 1,670,622 | +6.8% | 0.00% | 0.0% |
| Q1 2017 | $49,256,000 | +16.6% | 1,564,170 | +8.8% | 0.00% | +50.0% |
| Q4 2016 | $42,245,000 | +5.0% | 1,437,363 | +3.3% | 0.00% | 0.0% |
| Q3 2016 | $40,250,000 | +13.6% | 1,391,784 | +1.7% | 0.00% | 0.0% |
| Q2 2016 | $35,445,000 | +7.9% | 1,368,807 | +3.2% | 0.00% | 0.0% |
| Q1 2016 | $32,852,000 | -27.6% | 1,326,295 | +2.8% | 0.00% | -33.3% |
| Q4 2015 | $45,403,000 | -82.6% | 1,289,850 | -85.5% | 0.00% | -70.0% |
| Q3 2015 | $260,257,000 | +694.2% | 8,902,094 | +655.0% | 0.01% | +400.0% |
| Q2 2015 | $32,768,000 | -0.7% | 1,179,148 | +9.2% | 0.00% | 0.0% |
| Q1 2015 | $32,988,000 | +5.5% | 1,079,843 | +10.4% | 0.00% | 0.0% |
| Q4 2014 | $31,273,000 | +13.4% | 978,179 | +0.4% | 0.00% | 0.0% |
| Q3 2014 | $27,570,000 | +5.6% | 973,860 | +2.2% | 0.00% | 0.0% |
| Q2 2014 | $26,105,000 | +4.0% | 952,757 | -0.0% | 0.00% | 0.0% |
| Q1 2014 | $25,102,000 | -4.5% | 952,999 | +6.1% | 0.00% | 0.0% |
| Q4 2013 | $26,279,000 | -0.9% | 897,843 | +3.5% | 0.00% | -33.3% |
| Q3 2013 | $26,516,000 | +1.0% | 867,113 | +4.7% | 0.00% | 0.0% |
| Q2 2013 | $26,265,000 | – | 828,310 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $56,620,000 | 5.32% |
| Baker Brothers Advisors | 13,655,618 | $386,590,000 | 4.87% |
| NORTH TIDE CAPITAL, LLC | 1,500,000 | $42,465,000 | 3.24% |
| Murphy Michael R | 291,292 | $8,246,000 | 2.85% |
| Tributary Capital Management, LLC | 111,244 | $3,149,000 | 0.66% |
| Champlain Investment Partners, LLC | 1,234,780 | $34,957,000 | 0.61% |
| IRONBRIDGE CAPITAL MANAGEMENT LP | 454,085 | $12,855,000 | 0.34% |
| STONEBRIDGE CAPITAL MANAGEMENT INC | 27,180 | $769,000 | 0.30% |
| Motley Fool Asset Management LLC | 36,179 | $1,139,000 | 0.24% |
| Kimelman & Baird, LLC | 35,800 | $1,013,000 | 0.19% |